Intel to use ‘big data’ to battle Parkinson’s disease

Agence France-Presse

This is AI generated summarization, which may have errors. For context, always refer to the full article.

Intel to use ‘big data’ to battle Parkinson’s disease

EPA

Intel said it will work with the Michael J. Fox Foundation for Parkinson's Research on the effort to fight the neurodegenerative brain disease second only to Alzheimer's in worldwide prevalence

SAN FRANCISCO, USA – US computing giant Intel announced Wednesday, August 13, it was joining an effort to battle Parkinson’s disease with new big data and wearable technologies to improve research and treatment.

Intel said it would work with the Michael J. Fox Foundation for Parkinson’s Research – created by the “Back to the Future” Canadian-American actor – on the effort to fight the neurodegenerative brain disease second only to Alzheimer’s in worldwide prevalence.

The research will use “a new big data analytics platform that detects patterns in participant data collected from wearable technologies used to monitor symptoms,” an Intel statement said.

“This effort is an important step in enabling researchers and physicians to measure progression of the disease and to speed progress toward breakthroughs in drug development.”

The statement added that by collecting and analyzing data from thousands of individuals, such as slowness of movement, tremor and sleep quality, researchers can get a better picture of the progression of the disease.

The research will use wearables that “can unobtrusively gather and transmit objective, experiential data in real time, 24 hours a day, seven days a week,” according to the statement.

“Nearly 200 years after Parkinson’s disease was first described by Dr James Parkinson in 1817, we are still subjectively measuring Parkinson’s disease largely the same way doctors did then,” said Todd Sherer, chief executive of the foundation.

“Data science and wearable computing hold the potential to transform our ability to capture and objectively measure patients’ actual experience of disease, with unprecedented implications for Parkinson’s drug development, diagnosis and treatment.” – Rappler.com

Add a comment

Sort by

There are no comments yet. Add your comment to start the conversation.

Summarize this article with AI

How does this make you feel?

Loading
Download the Rappler App!